Cardiopulmonary Bypass Equipment-Medical Devices Pipeline Assessment, 2017
May 2017
98
About the Report
About the Report
Cardiopulmonary Bypass Equipment-Medical Devices Pipeline Assessment, 2017
Summary
GlobalData's Medical Devices sector report, "Cardiopulmonary Bypass Equipment-Medical Devices Pipeline Assessment, 2017" provides an overview of Cardiopulmonary Bypass Equipment currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiopulmonary Bypass Equipment pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Cardiopulmonary Bypass Equipment under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cardiopulmonary Bypass Equipment and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to buy
The report enables you to
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Cardiopulmonary Bypass Equipment under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date
Products
Products
AngioDynamics Inc, AngioVac Line Extension; Circulatory Technology Inc., Heart Lung Machine; Design Mentor, Inc., VentriFlo Pump; Emory University, Antegrade Catheter; LivaNova PLC , Heartlink System; LivaNova PLC , LBATS; Mayo Clinic US, Heart-Lung Machine Reservoir Sensor; Michigan Critical Care Consultants, Inc., Pediatric Blood Pump; Nikkiso Co., Ltd., Cardiopulmonary Bypass Pump; Nipro Corp, Venous And Arterial Cannula; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Centrifugal Blood Pump; Sree Chitra Tirunal Institute for Medical Sciences &; Technology, Paediatric And Neonatal Arterial Filter; University of Pittsburgh, Portable Emergency Cardiopulmonary Bypass Device; University of Strathclyde, Neonatal Life Support System
Companies
AngioDynamics Inc, Circulatory Technology Inc., Design Mentor, Inc., Emory University, LivaNova PLC, Mayo Clinic US, Michigan Critical Care Consultants, Inc., Nikkiso Co., Ltd., Nipro Corp, Sree Chitra Tirunal Institute for Medical Sciences & Technology, University of Pittsburgh, University of Strathclyde
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Cardiopulmonary Bypass Equipment Overview 6
3 Products under Development 7
3.1 Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 7
3.2 Cardiopulmonary Bypass Equipment-Pipeline Products by Territory 8
3.3 Cardiopulmonary Bypass Equipment-Pipeline Products by Regulatory Path 9
3.4 Cardiopulmonary Bypass Equipment-Pipeline Products by Estimated Approval Date 10
4 Cardiopulmonary Bypass Equipment-Pipeline Products under Development by Companies 11
4.1 Cardiopulmonary Bypass Equipment Companies-Pipeline Products by Stage of Development 11
4.2 Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 12
5 Cardiopulmonary Bypass Equipment Companies and Product Overview 13
5.1 AngioDynamics Inc Company Overview 13
5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 Circulatory Technology Inc. Company Overview 15
5.2.1 Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Design Mentor, Inc. Company Overview 16
5.3.1 Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.4 Emory University Company Overview 17
5.4.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 17
5.5 LivaNova PLC Company Overview 18
5.5.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Mayo Clinic US Company Overview 20
5.6.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 20
5.7 Michigan Critical Care Consultants, Inc. Company Overview 21
5.7.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.8 Nikkiso Co., Ltd. Company Overview 22
5.8.1 Nikkiso Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
5.9 Nipro Corp Company Overview 23
5.9.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 23
5.10 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 24
5.10.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 24
5.11 University of Pittsburgh Company Overview 26
5.11.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 26
5.12 University of Strathclyde Company Overview 27
5.12.1 University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 27
6 Cardiopulmonary Bypass Equipment- Recent Developments 28
6.1 May 02, 2017: Medline Names New President of Canadian Business 28
6.2 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 28
6.3 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 30
6.4 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 30
6.5 Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results 30
6.6 Mar 06, 2017: Medline Announces New Chief Marketing Officer 31
6.7 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 32
6.8 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 35
6.9 Feb 23, 2017: AtCor Signs Local Health System Agreement 35
6.10 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 35
6.11 Feb 09, 2017: Terumo Announces Change of Executive Officers 38
6.12 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 39
6.13 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 40
6.14 Jan 31, 2017: Terumo Opens a Branch in Yangon 42
6.15 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 42
6.16 Dec 30, 2016: Medline Makes it Easier for Patients to Receive Critical Supplies through New Patient Home Direct Deal with ViaQuest 43
6.17 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 44
6.18 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 45
6.19 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 46
6.20 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 49
6.21 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 50
6.22 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 51
6.23 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester 51
6.24 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results 52
6.25 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 53
6.26 Oct 24, 2016: Vascular Solutions Reports Third Quarter Results 55
6.27 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 58
6.28 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs 59
6.29 Oct 13, 2016: Mycobacterium chimaera Infections Associated with LivaNova Stockert 3T Heater-Cooler System 60
6.30 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 62
6.31 Sep 29, 2016: LivaNova Announces Half-Year Financial Report 63
6.32 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 71
6.33 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 72
6.34 Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results 75
6.35 Aug 01, 2016: LivaNova Names Chief Operating Officer 76
6.36 Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors 77
6.37 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 78
6.38 Jul 25, 2016: Vascular Solutions Reports Second Quarter Results 80
6.39 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 82
6.40 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results 83
6.41 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 84
6.42 Jul 12, 2016: McShane Construction Company Marks Significant Progress at New 630,000 S.F. Medical Supplies Distribution Center in Phoenix, Arizona 86
6.43 Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization 86
6.44 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 87
6.45 Jun 27, 2016: Medline and Medic Management Group Launch New GPO Distribution Partnership 87
6.46 Jun 21, 2016: MiMedx Reaches Settlement With Medline Industries And Liventa Bioscience For Certain Claims 88
6.47 Jun 10, 2016: FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility 89
6.48 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 89
6.49 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 90
6.50 May 23, 2016: New Distribution Partnership for Edward-Elmhurst Health's Physician Offices Results in Cost Savings of 10 Percent 93
6.51 May 19, 2016: Medline Inks Three-Year Prime Vendor Distribution Agreement with SBH Health System 93
7 Appendix 95
7.1 Methodology 95
7.2 About GlobalData 98
7.3 Contact Us 98
7.4 Disclaimer 98
List of Figure
1.2 List of Figures
Figure 1: Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 7
Figure 2: Cardiopulmonary Bypass Equipment-Pipeline Products by Territory 8
Figure 3: Cardiopulmonary Bypass Equipment-Pipeline Products by Regulatory Path 9
Figure 4: Cardiopulmonary Bypass Equipment-Pipeline Products by Estimated Approval Date 10
List of Table
1.1 List of Tables
Table 1: Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 7
Table 2: Cardiopulmonary Bypass Equipment-Pipeline Products by Territory 8
Table 3: Cardiopulmonary Bypass Equipment-Pipeline Products by Regulatory Path 9
Table 4: Cardiopulmonary Bypass Equipment-Pipeline Products by Estimated Approval Date 10
Table 5: Cardiopulmonary Bypass Equipment Companies-Pipeline Products by Stage of Development 11
Table 6: Cardiopulmonary Bypass Equipment-Pipeline Products by Stage of Development 12
Table 7: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 13
Table 8: AngioVac Line Extension-Product Status 13
Table 9: AngioVac Line Extension-Product Description 14
Table 10: Circulatory Technology Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 11: Heart Lung Machine-Product Status 15
Table 12: Heart Lung Machine-Product Description 15
Table 13: Design Mentor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 14: VentriFlo Pump-Product Status 16
Table 15: VentriFlo Pump-Product Description 16
Table 16: Emory University Pipeline Products & Ongoing Clinical Trials Overview 17
Table 17: Antegrade Catheter-Product Status 17
Table 18: Antegrade Catheter-Product Description 17
Table 19: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 18
Table 20: Heartlink System-Product Status 18
Table 21: Heartlink System-Product Description 19
Table 22: LBATS-Product Status 19
Table 23: LBATS-Product Description 19
Table 24: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 20
Table 25: Heart-Lung Machine Reservoir Sensor-Product Status 20
Table 26: Heart-Lung Machine Reservoir Sensor-Product Description 20
Table 27: Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 28: Pediatric Blood Pump-Product Status 21
Table 29: Pediatric Blood Pump-Product Description 21
Table 30: Nikkiso Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 31: Cardiopulmonary Bypass Pump-Product Status 22
Table 32: Cardiopulmonary Bypass Pump-Product Description 22
Table 33: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 23
Table 34: Venous And Arterial Cannula-Product Status 23
Table 35: Venous And Arterial Cannula-Product Description 23
Table 36: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 24
Table 37: Centrifugal Blood Pump-Product Status 24
Table 38: Centrifugal Blood Pump-Product Description 24
Table 39: Paediatric And Neonatal Arterial Filter-Product Status 25
Table 40: Paediatric And Neonatal Arterial Filter-Product Description 25
Table 41: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 26
Table 42: Portable Emergency Cardiopulmonary Bypass Device-Product Status 26
Table 43: Portable Emergency Cardiopulmonary Bypass Device-Product Description 26
Table 44: University of Strathclyde Pipeline Products & Ongoing Clinical Trials Overview 27
Table 45: Neonatal Life Support System-Product Status 27
Table 46: Neonatal Life Support System-Product Description 27
Table 47: Glossary 97
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.